Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Abbott describes use of new GR antagonists in diabetes Rx

April 23, 2001

Research at Ligand leads to identification of androgen receptor modulators

April 23, 2001

Banyu's new antidiabetic/antiobesity agents increase GLP-1 levels

April 23, 2001

Kyorin dedicates significant resources to the search for PPAR agonists

April 20, 2001

Pfizer patents new enzyme inhibitors with utility in lipid disorders, fungal infections, etc.

April 20, 2001

Chinese traditional medicine useful for aplastic anemia

April 20, 2001

Triterpenes with ACAT-inhibitory activity designed at Pola

April 19, 2001

Lipid-lowering effects of FPFS-410 characterized in animal studies

April 19, 2001

Novazyme's MPS I therapy receives orphan drug designation

April 19, 2001

Preclinical results for fidarestat discussed at diabetes meeting in Kyoto

April 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...